Any current/future new fundraising through debt or equity?

The transcript does not mention any current or planned fundraising through debt or equity. There is no discussion about issuing new shares or taking on additional debt. The company is focusing on growth through internal cash flow and approved capital expenditures, such as the $5.5 million capex in the U.S. and Rs. 30 crore for the Mundra facility expansion. No specific plans for fundraising via equity or debt were disclosed during the call.

Any current/future capex/capital investment/strategic investment?

Approved a capex of USD 5.5 million in the wholly owned U.S. subsidiary, CP Industries, to enhance manufacturing capabilities focused on larger diameter and Type 4 cylinders. This expansion is backed by customer contracts and aims to add approximately Rs. 100 crores to the top line in FY27-FY28. Additional capex of Rs. 30 crore approved to strengthen capabilities and enhance operational readiness at the greenfield Mundra facility in India; one production line is operational, with two more lines expected soon. Egypt facility progressing steadily, expected to commence operations by May 2026, aim

Future growth expectations in sales/revenue/volumes?

Targeting 15% to 20% growth in top line for FY27, driven by new facility and product mix. U.S. business expansion backed by $5.5 million capex, expected to add around Rs. 100 crores incremental revenue in FY27-FY28. Egypt facility to start by May 2026, with an expected revenue of Rs. 50-60 crores in the first year. UAE business expected to break even by FY27 with steady market recovery. India domestic growth supported by increasing CNG infrastructure and product acceptance, especially in commercial vehicles, defense, and semiconductor segments. Capacity expansion in Mundra plant to i

Future growth expectations in earnings/operating earnings/profits/EPS?

Targeted top-line growth of 15%-20% for FY27 with sustained margins around 15%-17%. Margins expected to remain stable, supported by favorable product mix and operational efficiencies. Incremental revenue of approximately Rs. 100 crores anticipated from U.S. business expansion by FY27-FY28, backed by customer contracts. New facilities at Mundra (operational with capacity expansion) and Egypt (expected operation by May 2026) to contribute positively. UAE business expected to break even by FY27, with improving market engagement. Overall, growth driven by expanding product offerings in higher-end

Current/ Expected Orderbook/ Pending Orders?

The current order book for the USA is around $75 million. Execution time for these orders is approximately 2 years. There is a strong order pipeline in the U.S. market, supported by customer contracts particularly for larger diameter and Type 4 cylinders. A $5.5 million capex has been approved in the U.S. subsidiary to enhance manufacturing capacity to meet this demand. Egypt facility is expected to start operations by May/June 2026, with customer approvals already in place and orders likely awaiting the facility’s start. Expected revenue from Egypt in the first year is around Rs. 50

IN US

Sale is live|00:00:00left today

Everest Kanto Cylinder LtdQ4 FY27Industrial Manufacturing

Everest Kanto Cylinder Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹123P/E: 10.9Market Cap: ₹1.3K CrSector: Industrial Manufacturing

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→Targeting 15% to 20% growth in top line for FY27, driven by new facility and product mix.
→U.S. business expansion backed by $5.5 million capex, expected to add around Rs. 100 crores incremental revenue in FY27-FY28.
→Egypt facility to start by May 2026, with an expected revenue of Rs. 50-60 crores in the first year.
→UAE business expected to break even by FY27 with steady market recovery.
→India domestic growth supported by increasing CNG infrastructure and product acceptance, especially in commercial vehicles, defense, and semiconductor segments.
→Capacity expansion in Mundra plant to increase capacity by around 15% by next quarter.
→Overall, new capacities, strong order pipeline, and operational efficiencies are expected to support steady and sustainable revenue growth.

Margin guidance

Category 3

→Targeted top-line growth of 15%-20% for FY27 with sustained margins around 15%-17%.
→Margins expected to remain stable, supported by favorable product mix and operational efficiencies.
→Incremental revenue of approximately Rs. 100 crores anticipated from U.S. business expansion by FY27-FY28, backed by customer contracts.
→New facilities at Mundra (operational with capacity expansion) and Egypt (expected operation by May 2026) to contribute positively.
→UAE business expected to break even by FY27, with improving market engagement.
→Overall, growth driven by expanding product offerings in higher-end segments such as defense, semiconductor, and composite cylinders.
→Continued capex investments (e.g., USD 5.5 million in U.S.) aimed to enable consistent and sticky revenue streams.
→Improvement in profitability and earnings anticipated from a combination of volume growth, improved realizations, and product mix optimization.

3 more insights locked — sign up free to unlock

Fundraise plans

→The transcript does not mention any current or planned fundraising through debt or equity.
→There is no discussion about issuing new shares or taking on additional debt.
→The company is focusing on growth through internal cash flow and approved capital expenditures, such as the $5.5 million capex in the U.S. and Rs. 30 crore for the Mundra facility expansion.
→No specific plans for fundraising via equity or debt were disclosed during the call.

Order book

Yes

→The current order book for the USA is around $75 million.
→Execution time for these orders is approximately 2 years.
→There is a strong order pipeline in the U.S. market, supported by customer contracts particularly for larger diameter and Type 4 cylinders.
→A $5.5 million capex has been approved in the U.S. subsidiary to enhance manufacturing capacity to meet this demand.
→Egypt facility is expected to start operations by May/June 2026, with customer approvals already in place and orders likely awaiting the facility’s start.
→Expected revenue from Egypt in the first year is around Rs. 50-60 crore.
→UAE sales have shown growth, with efforts to strengthen market engagement; however, recent quarters have seen subdued numbers due to a slowdown.
→Overall, the company maintains a healthy order pipeline with visibility for growth in the U.S., Egypt, and other markets.

Capex plans

Yes

→Approved a capex of USD 5.5 million in the wholly owned U.S. subsidiary, CP Industries, to enhance manufacturing capabilities focused on larger diameter and Type 4 cylinders. This expansion is backed by customer contracts and aims to add approximately Rs. 100 crores to the top line in FY27-FY28.
→Additional capex of Rs. 30 crore approved to strengthen capabilities and enhance operational readiness at the greenfield Mundra facility in India; one production line is operational, with two more lines expected soon.
→Egypt facility progressing steadily, expected to commence operations by May 2026, aimed at meeting domestic and regional demand, further expanding the global manufacturing footprint.

How does Everest Kanto Cylinder Ltd rank vs peers in Industrial Manufacturing?

Pro feature

1Everest Kanto Cylinder Ltd

Rev 3Mar 3

See full Industrial Manufacturing sector rankings

Want more stocks like Everest Kanto Cylinder Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio